1. Home
  2. STG vs RNXT Comparison

STG vs RNXT Comparison

Compare STG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunlands Technology Group

STG

Sunlands Technology Group

N/A

Current Price

$3.17

Market Cap

50.1M

Sector

Real Estate

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$1.42

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STG
RNXT
Founded
2003
2012
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.1M
42.4M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
STG
RNXT
Price
$3.17
$1.42
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
4.0K
317.3K
Earning Date
05-21-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
$1.10
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$2.44
$0.70
52 Week High
$11.53
$1.45

Technical Indicators

Market Signals
Indicator
STG
RNXT
Relative Strength Index (RSI) 43.63 79.87
Support Level $3.17 $0.82
Resistance Level $3.65 N/A
Average True Range (ATR) 0.13 0.09
MACD -0.01 0.04
Stochastic Oscillator 19.83 98.25

Price Performance

Historical Comparison
STG
RNXT

About STG Sunlands Technology Group

Sunlands Technology Group operates in China's adult online education market and adult personal interest learning market through its online platforms. The Group has a deep understanding of the educational needs of its prospective students and offers solutions to help them achieve their goals. It provides online professional courses and educational content, including interest, professional skills, professional certification preparation courses, and degree- or diploma-oriented post-secondary courses. The Group adopts a counseling-oriented sales and marketing approach to offer education solutions based on students' backgrounds and goals, delivering adult online education and personal interest learning through extensive course and content offerings.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: